Intuitive Surgical, Inc. $ISRG Stake Raised by Johnson Financial Group Inc.

Johnson Financial Group Inc. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 775 shares of the medical equipment provider’s stock after buying an additional 197 shares during the quarter. Johnson Financial Group Inc.’s holdings in Intuitive Surgical were worth $421,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 2.1% during the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares during the period. Geode Capital Management LLC grew its position in Intuitive Surgical by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after buying an additional 109,904 shares in the last quarter. Invesco Ltd. grew its position in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after buying an additional 71,794 shares in the last quarter. Northern Trust Corp increased its stake in Intuitive Surgical by 0.3% during the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after buying an additional 11,988 shares during the period. Finally, Wellington Management Group LLP raised its position in shares of Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of the business’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the sale, the executive vice president owned 5,758 shares in the company, valued at approximately $3,310,850. The trade was a 37.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the sale, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 86,804 shares of company stock worth $48,043,866 in the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $573.32 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The business’s fifty day moving average is $505.94 and its two-hundred day moving average is $505.46. The stock has a market capitalization of $205.52 billion, a P/E ratio of 75.84, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.84 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Truist Financial set a $620.00 price target on Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Mizuho set a $575.00 price target on Intuitive Surgical in a research report on Wednesday, October 22nd. Finally, HSBC upped their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.